Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea
· Delayed Price · Currency is KRW 1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 35.56 billion as of March 9, 2026. Its market cap has decreased by -69.37% in one year.
Market Cap
35.56B
Enterprise Value
37.38B
Revenue
938.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,087.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 35.56B, a decrease of -91.81%. That is a compound annual growth rate of -38.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 33.33B |
| SCM Lifescience | 38.01B |
| ADBiotech | 29.72B |
| J2KBIO | 45.32B |
| MOA Life Plus | 27.14B |
| NGeneBio | 53.15B |
| EyeGene | 56.54B |